1-3 of 3
ritp trial
Close
Save search
Sort by
Journal Articles

Rituximab Yielded a Significantly Longer Response Compared to Placebo in Steroid Free Population - a Post Hoc Analysis of the Ritp Study

Free
Waleed Ghanima, MD PhD, Marc Michel, Abderrahim Khelif, Bernadette Darne, Pal André Holme, PhDMD
Journal: Blood
Blood (2019) 134 (Supplement_1): 2358.
https://doi.org/10.1182/blood-2019-126975
Published: 2019
Journal Articles

The Risk of Thromboembolism Associated with Treatment of ITP with Rituximab: Adverse Event Reported in Two Randomized Controlled Trials

Free
Lamya Garabet, Pal André Holme, PhDMD, Bernadette Darne, Abderrahim Khelif, Tor Henrik Anderson Tvedt, MD, Marc Michel, Waleed Ghanima, MD PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 4892.
https://doi.org/10.1182/blood-2019-126974
Published: 2019
Journal Articles

Rituximab As Second Line Treatment For Adult Immune Thrombocytopenia (ITP): A Multicentre, Randomized, Double Blind, Placebo-Controlled Study – The Ritp Study (NCT00344149)

Free
Waleed Ghanima, MD, PhD, Abderrahim Khelif, Neila Benromdhan, MD, Anders Waage, MD, PhD, Geir E. Tjonnfjord, MD, PhD, Marc Michel, Darne Bernadette, MD, Johannes Kahrs, MD, Pål Andre Holme, MD, PhD
Journal: Blood
Blood (2013) 122 (21): 449.
https://doi.org/10.1182/blood.V122.21.449.449
Published: 2013